DNA sequencing and metabolomics: New approaches to the forensic assessment of herbal therapeutic agents

Forensic Science, Medicine, and Pathology

Volumn 11, Issue 1, 2015, Pages

  Byard, Roger W ^a   Musgrave, Ian ^a   Hoban, Claire ^a   Bunce, Michael ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b CURTIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GENETIC MARKER; PLANT DNA; PLANT MEDICINAL PRODUCT;

ADVERSE EFFECTS; AUTOPSY; CAUSE OF DEATH; DNA SEQUENCE; FORENSIC TOXICOLOGY; GENETIC MARKER; GENETICS; HERB DRUG INTERACTION; HUMAN; MEDICINAL PLANT; METABOLISM; METABOLOMICS; PHYTOTHERAPY; PROCEDURES;

AUTOPSY; CAUSE OF DEATH; DNA, PLANT; FORENSIC TOXICOLOGY; GENETIC MARKERS; HERB-DRUG INTERACTIONS; HUMANS; METABOLOMICS; PHYTOTHERAPY; PLANT PREPARATIONS; PLANTS, MEDICINAL; SEQUENCE ANALYSIS, DNA;

EID: 84930193281     PISSN: 1547769X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12024-014-9537-8     Document Type: Editorial

References (9)

1. Byard RW. The potential forensic significance of traditional herbal medicines. J Forensic Sci. 2010;55:89–92.
2. Byard RW, Musgrave I. Herbal medicines and forensic investigations. Forensic Sci Med Pathol. 2010;6:81–2.
3. Byard RW, James RA, Felgate P. Detecting organic toxins in possible fatal poisonings—a diagnostic problem. J Clin Forensic Med. 2002;9:85–8.
4. Kostakis C, Byard RW. Sudden death associated with intravenous injection of toad extract. Forensic Sci Int. 2009;188:e1–5.
5. Coghlan ML, Haile J, Houston J, et al. Deep sequencing of plant and animal DNA contained within traditional Chinese medicines reveals legality issues and health safety concerns. PLoS Genet. 2012;8:1–11.
6. Chen R, Dong J, Cui X, et al. DNA based identification of medicinal materials in Chinese patent medicines. Sci Rep. 2012;2:958.
7. Robertson DG, Watkins PB, Reily MD. Metabolomics in toxicology: preclinical and clinical applications. Toxicol Sci. 2011;120(S1): S146–70.
8. Junot C, Fenaille F, Colsch B, Becher F. High resolution mass spectroscopy based techniques at the crossroads of metabolic pathways. Mass Spectrom Rev. 2013;. doi:10.1002/mas.21401.
9. Nordström A, Lewensohn R. Metabolomics: moving to the clinic. J Neuroimmune Pharmacol. 2010;5:4–7.